|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 70.70 USD | +1.23% |
|
+1.25% | +143.12% |
| Nov. 10 | Avidity Biosciences reports wider-than-expected Q3 net loss | RE |
| Nov. 10 | Avidity Biosciences, Inc. Reports Earnings Results for the Third Quarter and Nine Months Ended September 30, 2025 | CI |
Chart calendar Avidity Biosciences, Inc.
Upcoming events on Avidity Biosciences, Inc.
| 2026-03-02 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple Default |
| 2026-05-11 | Q1 2026 Earnings Release (Projected) | Add to your calendar Google Apple Default |
| 2026-08-10 | Q2 2026 Earnings Release (Projected) | Add to your calendar Google Apple Default |
Past events on Avidity Biosciences, Inc.
| 2025-11-10 | Q3 2025 Earnings Release (Projected) |
| 2025-10-21 | Chardan Genetic Medicines Conference |
| 2025-10-11 | International Society of World Muscle Congress - Kevin M. Flanigan |
| 2025-10-08 | International Society of World Muscle Congress - Aravindhan Veerapandiyan |
| 2025-09-18 | CureDuchenne Webinar |
| 2025-09-10 | EXPLORE44® and EXPLORE44-OLE™ Phase 1/2 Trial Results Call |
| 2025-09-08 | Morgan Stanley Global Healthcare Conference |
| 2025-09-04 | Wells Fargo Healthcare Conference |
| 2025-09-03 | Cantor Global Healthcare Conference |
| 2025-08-07 | Q2 2025 Earnings Release |
| 2025-06-13 | FSHD Society International Research Congress |
| 2025-06-12 | FSHD Society International Research Congress - Poster No 708 |
| 2025-06-12 | FSHD Society International Research Congress |
| 2025-06-11 | FSHD Society International Research Congress |
| 2025-06-10 | Annual General Meeting |
| 2025-06-09 | FORTITUDE™ Phase 1/2 Trial Results Call |
| 2025-05-13 | Bank of America Global Healthcare Conference |
| 2025-05-08 | Q1 2025 Earnings Release |
| 2025-04-08 | Needham Healthcare Conference |
| 2025-03-19 | Muscular Dystrophy Association Clinical and Scientific Conference - Oral Presentation |
Annual results
| Fiscal Period | December | 2022 | 2023 | 2024 | 2025 | 2026 | 2027 |
|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 9,22 8,33 10.75% | 9,56 19,6 -51.18% | 10,9 9,75 11.76% | 8,80 | 14,9 | 242 |
|
EBITDA Million USD | Released Forecast Spread | -178 -182 2.48% | -233 -229 -1.79% | -376 -354 -6.39% | -633 | -686 | -351 |
|
EBIT Million USD | Released Forecast Spread | -179 -176 -1.64% | -236 -215 -9.38% | -379 -361 -5.04% | -686 | -692 | -507 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -174 -174 -0.24% | -212 -195 -8.63% | -322 -322 -0.11% | -626 | -704 | -645 |
|
Net income Million USD | Released Forecast Spread | -174 -173 -0.32% | -212 -200 -6.21% | -322 -322 -0.14% | -630 | -676 | -603 |
|
EPS USD | Released Forecast Spread | -3,34 -3,35 0.43% | -2,91 -2,76 -5.43% | -2,89 -2,89 0.07% | -4,75 | -4,79 | -4,11 |
| Announcement Date | 28/02/23 | 28/02/24 | 27/02/25 | - |
Quarterly results
| Fiscal Period | September | 2024 Q1 | 2024 Q2 | 2024 Q3 | 2024 Q4 | 2025 Q1 | 2025 Q2 | 2025 Q3 | 2025 Q4 | 2026 Q1 | 2026 Q2 | 2026 Q3 | 2026 Q4 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
|
Net sales Million USD | Released Forecast Spread | 3,54 2,57 37.85% | 2,05 3,01 -32.13% | 2,34 4,58 -48.99% | 2,97 1,74 70.58% | 1,57 2,62 -40.07% | 3,85 1,61 139.64% | 12,5 1,81 590.03% | 2,11 | 3,09 | 3,19 | 2,97 | 4,97 |
|
EBITDA Million USD | Released Forecast Spread | -76,5 -64,6 -18.4% | -81,9 -60,8 -34.86% | -97,4 -80,9 -20.38% | -120 -98,6 -21.95% | -131 -121 -8.19% | -170 -128 -33.17% | -188 -151 -24.74% | -151 | -168 | -169 | ||
|
EBIT Million USD | Released Forecast Spread | -77,2 -67,4 -14.49% | -82,6 -74,5 -10.91% | -98,1 -80,4 -22.04% | -121 -103 -17.55% | -132 -122 -7.79% | -171 -134 -27.57% | -189 -162 -16.75% | -195 | -178 | -184 | -191 | -189 |
|
Earnings before Tax (EBT) Million USD | Released Forecast Spread | -68,9 -64,5 -6.7% | -70,8 -74,6 5.06% | -80,4 -72,2 -11.36% | -102 -102 -0.33% | -116 -123 6.03% | -157 -135 -16.67% | -174 -163 -6.9% | -178 | -176 | -182 | -187 | -185 |
|
Net income Million USD | Released Forecast Spread | -68,9 -65,5 -5.19% | -70,8 -72,6 2.49% | -80,4 -75,8 -6.08% | -102 -102 -0.43% | -116 -116 0.21% | -157 -128 -23.07% | -174 -154 -13.38% | -182 | -186 | -188 | -192 | -190 |
|
EPS USD | Released Forecast Spread | -0,79 -0,87 8.67% | -0,65 -0,79 17.85% | -0,65 -0,72 9.09% | -0,80 -0,78 -2.71% | -0,90 -0,85 -6.3% | -1,21 -0,98 -23.58% | -1,27 -1,11 -14.41% | -1,33 | -1,25 | -1,28 | -1,30 | -1,31 |
| Announcement Date | 09/05/24 | 09/08/24 | 07/11/24 | 27/02/25 | 08/05/25 | 07/08/25 | 10/11/25 | - | - | - | - | - |
| 2025-11-12 | Q2 2026 Earnings Release | Add to your calendar Google Apple Default | |
| 2025-11-14 | Q4 2025 Earnings Release | Add to your calendar Google Apple Default | |
| 2025-11-16 | Q3 2025 Earnings Release (Projected) | Add to your calendar Google Apple Default | |
| 2025-11-17 | Q3 2025 Earnings Release (Projected) | Add to your calendar Google Apple Default | |
| 2026-01-27 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple Default | |
| 2026-01-28 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple Default | |
| 2026-01-29 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple Default | |
| 2026-01-29 | Q1 2026 Earnings Release (Projected) | Add to your calendar Google Apple Default | |
| 2026-02-04 | Q3 2026 Earnings Release (Projected) | Add to your calendar Google Apple Default | |
| 2026-02-04 | Q4 2025 Earnings Release (Projected) | Add to your calendar Google Apple Default |
Past sector events for Avidity Biosciences, Inc.
| Today | Q3 2025 Earnings Release (Projected) | |
| Today | Q3 2025 Earnings Release (Projected) | |
| 2025-11-10 | Q3 2025 Earnings Release (Projected) | |
| 2025-11-10 | October 2025 Sales and Revenue Release | |
| 2025-11-09 | Q3 2025 Earnings Release | |
| 2025-11-09 | Q3 2025 Earnings Release | |
| 2025-11-06 | Q3 2025 Earnings Release | |
| 2025-11-06 | Q3 2025 Earnings Release | |
| 2025-11-06 | Q3 2025 Earnings Release | |
| 2025-11-05 | Q3 2025 Earnings Release |
Quarterly revenue - Rate of surprise
Net sales - Rate of surprise
Annual profits - Rate of surprise
- Stock Market
- Equities
- RNA Stock
- Calendar Avidity Biosciences, Inc.
Select your edition
All financial news and data tailored to specific country editions
















